September 2, 2008 - Health Discovery Corp. (HDC) said it has signed a licensing agreement with Smart Personalized Medicine LLC, founded by Richard Caruso, M.D., chairman and founder of Intergra Life Sciences) to work to develop a breast cancer prognostic test using HDC�s support vector machine (SVM) technology in collaboration with MD Anderson Cancer Center.
Under the terms of the Agreement, HDC will receive a 15 percent equity position in Smart Personalized Medicine based on up to a $5 million initial investment from Smart Personalized Medicine LLC investors. In addition, HDC will receive a per test royalty up to 7.5 percent based on net proceeds received from the sale of the new breast cancer prognostic test.
For more information; www.healthdiscoverycorp.com
October 30, 2026 
